Divi's Laboratories · NSE: DIVISLAB · BSE: 532488
Q3 FY19 results · Oct–Dec 2018
Divi's Laboratories reported revenue from operations of ₹1,342.92 crore and net profit of ₹379.49 crore for Q3 FY19 (Oct–Dec 2018), on a standalone basis.
| Item | Q3 FY19 | Q3 FY18 | YoY | Q2 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,342.92 | — | — | 1,285.00 | +4.5% |
| Other income | 34.56 | — | — | 80.05 | −56.8% |
| Total income | 1,377.48 | — | — | 1,365.05 | +0.9% |
| Profit before tax | 512.89 | — | — | 551.55 | −7.0% |
| Net profit for the period | 379.49 | — | — | 397.65 | −4.6% |
| EPS, basic (₹) | 14.29 | — | — | 14.98 | −4.6% |
| Net margin (%) | 28.3 | — | 30.9 |
Standalone
- Filed with BSE
- 02 Feb 2019, 16:13 IST
- Board meeting
- 02 Feb 2019
- Period
- 01 Oct 2018 to 31 Dec 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE